Wiley Interdisciplinary Reviews - RNA,
Год журнала:
2023,
Номер
15(1)
Опубликована: Ноя. 13, 2023
Abstract
PARP1
(poly‐ADP‐ribose
polymerase
1)
is
a
multidomain
protein
with
flexible
and
self‐folding
structure
that
allows
it
to
interact
wide
range
of
biomolecules,
including
nucleic
acids
target
proteins.
interacts
its
molecules
either
covalently
via
PARylation
or
non‐covalently
through
PAR
moieties
induced
by
auto‐PARylation.
These
diverse
interactions
allow
participate
in
complex
regulatory
circuits
cellular
functions.
Although
the
most
studied
PARP1‐mediated
functions
are
associated
DNA
repair
stress
response,
subsequent
discoveries
have
revealed
additional
biological
Based
on
these
findings,
now
recognized
as
major
modulator
gene
expression.
Several
show
this
multifunctional
has
been
intimately
connected
several
steps
mRNA
biogenesis,
from
transcription
initiation
splicing,
polyadenylation,
export,
translation
Nevertheless,
our
understanding
PARP1's
involvement
biogenesis
both
coding
noncoding
RNA,
notably
circular
RNA
(circRNA),
remains
restricted.
In
review,
we
outline
possible
roles
circRNA
biogenesis.
A
full
examination
nuclear
processes
an
emphasis
may
reveal
new
avenues
control
dysregulation
implicated
pathogenesis
diseases
such
neurodegenerative
disorders
cancers.
This
article
categorized
under:
Interactions
Proteins
Other
Molecules
>
Protein‐RNA
Interactions:
Functional
Implications
Regulatory
RNAs/RNAi/Riboswitches
RNAs
Processing
Splicing
Regulation/Alternative
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(20), С. 10926 - 10926
Опубликована: Окт. 11, 2024
Circadian
rhythms,
the
internal
timekeeping
systems
governing
physiological
processes,
significantly
influence
skin
health,
particularly
in
response
to
ultraviolet
radiation
(UVR).
Disruptions
circadian
rhythms
can
exacerbate
UVR-induced
damage
and
increase
risk
of
aging
cancer.
This
review
explores
how
affect
various
aspects
physiology
pathology,
with
a
special
focus
on
DNA
repair.
regulation
ensures
optimal
repair
following
damage,
reducing
mutation
accumulation,
enhancing
genomic
stability.
The
control
over
cell
proliferation
apoptosis
further
contributes
regeneration
UVR.
Oxidative
stress
management
is
another
critical
area
where
exert
influence.
Key
genes
like
brain
muscle
ARNT-like
1
(BMAL1)
locomotor
output
cycles
kaput
(CLOCK)
modulate
activity
antioxidant
enzymes
signaling
pathways
protect
cells
from
oxidative
stress.
also
inflammatory
immune
responses
by
modulating
Langerhans
other
skin.
In
summary,
form
complex
defense
network
that
manages
through
precise
repair,
proliferation,
apoptosis,
response,
stress,
hormonal
signaling.
Understanding
these
mechanisms
provides
insights
into
developing
targeted
protection
improving
cancer
prevention.
PARP
inhibitors
(PARPi)
represent
a
game-changing
treatment
for
patients
with
ovarian
cancer
tumors
deficient
the
homologous
recombination
(HR)
pathway
treated
platinum
(Pt)-based
therapy.
PARPi
exert
their
cytotoxic
effect
by
both
trapping
PARP1
on
damaged
DNA
and
restraining
its
enzymatic
activity
(PARylation).
How
is
recruited
trapped
at
damage
sites
how
resistance
to
could
be
overcome
are
still
matters
of
investigation.
Here,
we
described
as
substrate
deubiquitinase
USP1.
At
molecular
level,
USP1
binds
remove
K63-linked
polyubiquitination
controls
chromatin
PARylation
activity,
regulating
sensitivity
PARPi.
In
Pt/PARPi-sensitive
-resistant
cells,
USP1/PARP1
combined
blockade
enhances
replicative
stress,
damage,
cell
death.
Our
work
dissected
biological
interaction
between
recommended
this
axis
promising
powerful
therapeutic
choice
not
only
sensitive
but
also
chemoresistant
irrespective
HR
status.
Cells,
Год журнала:
2024,
Номер
13(16), С. 1348 - 1348
Опубликована: Авг. 14, 2024
Uveal
melanoma
(UM)
is
the
most
common
primary
intraocular
tumor
in
adults,
with
no
standardized
treatment
for
advanced
disease.
Based
on
preliminary
bioinformatical
analyses
DTYMK
and
PARP1
were
selected
as
potential
therapeutic
targets.
High
levels
of
both
proteins
detected
uveal
cells
correlated
increased
growth
poor
prognosis.
In
vitro
tests
MP41
(BAP1
positive)
MP46
negative)
cancer
cell
lines
using
inhibitors
pamiparib
(PARP1)
Ymu1
(DTYMK)
demonstrated
significant
cytotoxic
effects.
Combined
had
synergistic
effects
additive
lines,
reducing
proliferation
inhibiting
mTOR
signaling
pathway.
Furthermore,
applied
combination
decreased
motility
migration
speed,
especially
BAP1-negative
lines.
Our
hypothesis
double
hit
into
tumoral
DNA
metabolism
a
possible
option
was
confirmed
since
combined
targeting
affected
all
tested
cytophysiological
parameters
highest
efficiency.
findings
provide
insights
novel
avenues
managing
melanoma,
warranting
further
exploration
preclinical
clinical
settings.
Investigative Ophthalmology & Visual Science,
Год журнала:
2024,
Номер
65(12), С. 37 - 37
Опубликована: Окт. 24, 2024
The
gene
encoding
nicotinamide
mononucleotide
adenylyltransferase
1
(NMNAT1),
a
adenine
dinucleotide
synthetase
localized
in
the
cell
nucleus,
is
causative
factor
Leber's
congenital
amaurosis,
which
earliest
onset
type
of
inherited
retinal
degeneration.
We
sought
to
investigate
roles
NMNAT1
early
development.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Окт. 27, 2024
Abstract
Accumulation
of
senescent
cells
drives
aging
and
age-related
diseases.
Senolytics,
which
selectively
kill
cells,
offer
a
promising
approach
for
treating
many
Using
cell-based
phenotypic
drug
discovery
that
combines
screening
design,
we
developed
two
novel
flavonoid
senolytics,
SR29384
SR31133,
derived
from
the
senolytic
fisetin.
These
compounds
demonstrated
enhanced
activities,
effectively
eliminating
multiple
cell
types,
reducing
tissue
senescence
in
vivo
,
extending
healthspan
mouse
model
accelerated
aging.
Mechanistic
studies
utilizing
RNA-Seq,
machine
learning,
network
pharmacology,
computational
simulation
suggest
these
senolytics
target
PARP1,
BCL-xL,
CDK2
to
induce
selective
death.
This
phenotype-based
coupled
with
mechanistic
insights,
represents
key
advancement
developing
next-generation
senolyticss
potential
clinical
applications
Proceedings of the National Academy of Sciences,
Год журнала:
2024,
Номер
122(1)
Опубликована: Дек. 31, 2024
Poly(ADP-ribose)
polymerase
1
(PARP1)
plays
a
crucial
role
in
DNA
repair
and
genomic
stability
maintenance.
However,
the
regulatory
mechanisms
governing
PARP1
activity,
particularly
through
deubiquitination,
remain
poorly
elucidated.
Using
deubiquitinase
(DUB)
library
binding
screen,
we
identified
cylindromatosis
(CYLD)
as
bona
fide
DUB
for
breast
cancer
cells.
Mechanistically,
CYLD
is
recruited
by
to
lesions
upon
genotoxic
stress,
where
it
cleaves
K63-linked
polyubiquitin
chains
on
at
residues
K748,
K940,
K949,
resulting
compromised
activation.
In
reciprocal
manner,
PARylates
sites
E191,
E231,
E259,
E509,
thereby
enhancing
its
activity.
Consequently,
depletion
of
leads
increased
efficiency
base
excision
confers
cells
with
resistance
alkylating
agents.
Conversely,
overexpression
enhances
sensitivity
PARP
inhibitors
(PARPi)
even
homologous
recombination-proficient
These
findings
offer
unique
insights
into
intricate
interplay
between
repair,
underscoring
pivotal
targeting
this
axis
chemotherapy.
This
thesis
explores
the
interaction
between
two
key
proteins,
Banf1
and
PARP1,
which
play
crucial
roles
in
DNA
repair.
Using
advanced
techniques
like
mass
photometry,
spectroscopy,
electron
microscopy,
research
reveals
how
regulates
PARP1's
activity
by
binding
to
its
catalytic
domain.
is
significant
for
maintaining
genomic
stability,
with
implications
diseases
such
as
cancer,
where
repair
processes
are
often
disrupted.
The
findings
contribute
understanding
these
proteins
function
together,
potentially
paving
way
new
therapeutic
strategies
targeting
PARP1
cancer
treatment.
Abstract
Target
engagement
assays
typically
detect
and
quantify
the
direct
physical
interaction
of
a
protein
interest
its
ligand
through
stability
changes
upon
binding.
Commonly
used
target
methods
ligand‐induced
by
subjecting
samples
to
thermal
or
proteolytic
stress.
Here
we
describe
new
variation
these
approaches
called
Isothermal
Ligand‐induced
Resolubilization
Assay
(ILIRA),
which
utilizes
lyotropic
solubility
stress
measure
binding
in
solubility.
We
identified
distinct
buffer
systems
salt
concentrations
that
compromised
for
four
diverse
proteins:
dihydrofolate
reductase
(DHFR),
nucleoside
diphosphate‐linked
moiety
X
motif
5
(NUDT5),
poly
[ADP‐ribose]
polymerase
1
(PARP1),
arginine
N
‐methyltransferase
(PRMT1).
rescue
was
demonstrated
proteins,
suggesting
ILIRA
can
be
as
an
additional
technique.
Differences
were
assessed
Coomassie
blue
staining
SDS‐PAGE
dot
blot,
well
NanoOrange,
Thioflavin
T,
Proteostat
fluorescence,
thus
offering
flexibility
readout
assay
throughput.
Clinical Medicine Insights Oncology,
Год журнала:
2024,
Номер
18
Опубликована: Янв. 1, 2024
Background:
Acute
myeloid
leukemia
(AML)
has
a
heterogeneous
molecular
profile,
clinical
presentations,
and
response
to
treatments
outcomes.
DNA
methylation
is
conducted
by
methyltransferases
including
DNMT3B.
Poly
ADP-ribose
polymerase
1
belongs
family
of
enzymes
that
mediate
important
cellular
processes
repair,
transcription,
cell
death/cell
proliferation,
it
involved
in
the
development,
spread,
treatment,
prognosis
some
cancers.
The
objective
this
study
assess
impact
PARP1
DNMT3B
genes
expression
on
laboratory
characteristics,
treatment
survival
Egyptian
cytogenetically
normal
AML
patients.
Methods:
This
included
67
CN-AML
patients
addition
8
healthy
bone
marrow
donors.
Measurement
gene
was
done
samples
via
real-time
semiquantitative
chain
reaction.
Result:
Expression
both
significantly
upregulated
(
P
=
.001,
.036,
respectively).
Upregulated
associated
with
higher
total
leukocyte
count
(TLC),
PB,
BM
blast
cell%.
Also,
correlated
TLC,
High
greater
frequencies
FLT3-ITD.
expression,
combined
upregulation
ELN
stratification.
But
no
correlation
found
(CR),
overall
(OS),
disease-free
(DFS),
or
event-free
(EFS).
Conclusion:
Our
findings
highlight
importance
considering
levels
as
potential
prognostic
biomarkers
for
progression
aggressiveness
AML.
Assessing
their
could
be
an
indicator
guide
decisions
potentially
improve
patient